Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.82 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.67 |
| ▸ | DGKA | P23743 | 2/20 | 0.65 |
| ▸ | CNR2 | P34972 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93861 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL324737 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL29454638 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL15664437 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL15664438 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL10529166 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL10715660 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL10491614 | 0.98 | MGLL (0.80) | MGLLEPHX2DGKACNR2MAPT | |
| Ethylene SCHEMBL10418119 | 0.97 | MGLL (0.78) | MGLLEPHX2DGKACNR2MAPT | |
| Ethylene SCHEMBL1564174 | 0.97 | MGLL (0.78) | MGLLEPHX2DGKACNR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| US-20240207408-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2024-06-27 | — | — | US | disclosed |
| US-11992555-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2024-05-28 | — | — | US | disclosed |
| US-11918654-B2 | Solid solution compositions and use in severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2024-03-05 | — | — | US | disclosed |
| US-11844773-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2023-12-19 | — | — | US | disclosed |
| US-11826428-B2 | Solid solution compositions comprising cannabidiols | INFIRST HEALTHCARE LIMITED (GB) | 2023-11-28 | — | — | US | disclosed |
| US-11730709-B2 | Compositions and methods for treating severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2023-08-22 | — | — | US | disclosed |
| US-20220118091-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2022-04-21 | — | — | US | disclosed |
| CN-109549927-B | Solid solution compositions and their use in cardiovascular disease | 因佛斯特医疗有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-11224659-B2 | Solid solution compositions and use in severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2022-01-18 | — | — | US | disclosed |
| US-8568563-B1 | Methods of making a non-woven fire barrier mat | Jonhs Manville (US) | 2013-10-29 | — | — | US | disclosed |
| US-20130240781-A1 | Ozonolysis Reactions in Liquid CO2 and CO2-Expanded Solvents | ARCHER DANIELS MIDLAND COMPANY (US) | 2013-09-19 | — | — | US | disclosed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | disclosed |
| US-20130045352-A1 | NON-WOVEN FIRE BARRIER MAT | JOHNS MANVILLE | 2013-02-21 | — | — | US | disclosed |
| EP-2209547-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | University Of Kansas (US) | 2010-07-28 | — | — | EP | disclosed |
| WO-2009061806-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIVERSITY OF KANSAS (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090118498-A1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | ARCHER DANIELS MIDLAND COMPANY | 2009-05-07 | — | — | US | disclosed |
| US-20050101542-A1 | Combination therapy for controlling appetites | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-05-12 | — | — | US | disclosed |
| WO-2004034968-A2 | COMBINATION THERAPY FOR CONTROLLING APPETITES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-04-29 | — | — | WO | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101542-A1 | Combination therapy for controlling appetites | FAAH, FAAH2, GPR119 | MGLL 12/4885EPHX2 330/4885DGKA 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.